These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28704121)

  • 1. Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates.
    Nakaminami H; Tanuma K; Enomoto K; Yoshimura Y; Onuki T; Nihonyanagi S; Hamada Y; Noguchi N
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):629-634. PubMed ID: 28704121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole.
    Talbott M; Cevallos V; Chen MC; Chin SA; Lalitha P; Seitzman GD; Lietman TM; Keenan JD
    Cornea; 2019 Oct; 38(10):1309-1313. PubMed ID: 31306283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
    Omaña-Molina M; Vanzzini-Zago V; Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Salazar-Villatoro L; González-Robles A; Ramírez-Flores E; Servín-Flores C; Flores-Alvarado V; Alcántara-Castro M; Lorenzo-Morales J
    Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of effective treatment drugs against Acanthamoeba cyst].
    Tahara K; Asari S; Shimomura Y; Endo T; Yanagihara T
    Kansenshogaku Zasshi; 1997 Oct; 71(10):1025-30. PubMed ID: 9394554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
    Elder MJ; Kilvington S; Dart JK
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1059-64. PubMed ID: 8125716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acanthamoeba griffini. Molecular characterization of a new corneal pathogen.
    Ledee DR; Hay J; Byers TJ; Seal DV; Kirkness CM
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):544-50. PubMed ID: 8595954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge.
    Schroeder JM; Booton GC; Hay J; Niszl IA; Seal DV; Markus MB; Fuerst PA; Byers TJ
    J Clin Microbiol; 2001 May; 39(5):1903-11. PubMed ID: 11326011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba.
    Lim L; Coster DJ; Badenoch PR
    Clin Exp Ophthalmol; 2000 Apr; 28(2):119-24. PubMed ID: 10933775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro development of an effective treatment for Acanthamoeba keratitis.
    Ortillés Á; Belloc J; Rubio E; Fernández MT; Benito M; Cristóbal JÁ; Calvo B; Goñi P
    Int J Antimicrob Agents; 2017 Sep; 50(3):325-333. PubMed ID: 28709990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of Acanthamoeba keratitis by hexamidine.
    Brasseur G; Favennec L; Perrine D; Chenu JP; Brasseur P
    Cornea; 1994 Sep; 13(5):459-62. PubMed ID: 7995072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 18S ribosomal DNA genotype of Acanthamoeba from patients with keratitis in North China.
    Zhang Y; Sun X; Wang Z; Li R; Luo S; Jin X; Deng S; Chen W
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1904-7. PubMed ID: 15161856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
    Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
    Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiamoebic Susceptibility in Acanthamoeba Keratitis: Comparison of Isolates From South India and Northern California.
    Richardson QR; Prajna L; Elakkiya S; Kamal FS; Talbott M; Prajna NV; Rajaraman R; Cevallos V; Seitzman GD; Lietman TM; Keenan JD
    Cornea; 2023 Jan; 42(1):110-112. PubMed ID: 36036669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
    Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Vanzzini-Zago V; Ramírez-Flores E; Sifaoui I; Piñero JE; Lorenzo-Morales J; Omaña-Molina M
    Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
    Gueudry J; Le Goff L; Compagnon P; Lefevre S; Colasse E; Aknine C; Duval F; François A; Razakandrainibe R; Ballet JJ; Muraine M; Favennec L
    J Antimicrob Chemother; 2018 Jul; 73(7):1895-1898. PubMed ID: 29596605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
    JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
    Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J
    Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and molecular characterization of Acanthamoeba from patients with keratitis in Spain.
    Martín-Pérez T; Criado-Fornelio A; Martínez J; Blanco MA; Fuentes I; Pérez-Serrano J
    Eur J Protistol; 2017 Oct; 61(Pt A):244-252. PubMed ID: 28756938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.